Cargando…

Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers

Human endogenous retroviruses (HERV) form a substantial part of the human genome, but mostly remain transcriptionally silent under strict epigenetic regulation, yet can potentially be reactivated by malignant transformation or epigenetic therapies. Here, we evaluate the potential for T cell recognit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saini, Sunil Kumar, Ørskov, Andreas Due, Bjerregaard, Anne-Mette, Unnikrishnan, Ashwin, Holmberg-Thydén, Staffan, Borch, Annie, Jensen, Kathrine Valentini, Anande, Govardhan, Bentzen, Amalie Kai, Marquard, Andrea Marion, Tamhane, Tripti, Treppendahl, Marianne Bach, Gang, Anne Ortved, Dufva, Inge Høgh, Szallasi, Zoltan, Ternette, Nicola, Pedersen, Anders Gorm, Eklund, Aron Charles, Pimanda, John, Grønbæk, Kirsten, Hadrup, Sine Reker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653045/ https://www.ncbi.nlm.nih.gov/pubmed/33168830 http://dx.doi.org/10.1038/s41467-020-19464-8

Ejemplares similares

Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies
por: Saini, Sunil Kumar, et al.
Publicado: (2022)

Evolution of MHC-based technologies used for detection of antigen-responsive T cells
por: Bentzen, Amalie Kai, et al.
Publicado: (2017)

T-cell-receptor cross-recognition and strategies to select safe T-cell receptors for clinical translation
por: Bentzen, Amalie Kai, et al.
Publicado: (2019)

Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations
por: Hansen, Ulla Kring, et al.
Publicado: (2020)

CD8(+) T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens
por: Pedersen, Natasja Wulff, et al.
Publicado: (2019)

Immune Mechanisms in Myelodysplastic Syndrome
por: Glenthøj, Andreas, et al.
Publicado: (2016)

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8(+) T cell activation in COVID-19 patients
por: Saini, Sunil Kumar, et al.
Publicado: (2021)

Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8(+) T cell immunity in CLL and MDS patients
por: Hernandez, Susana Patricia Amaya, et al.
Publicado: (2023)

An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
por: Bjerregaard, Anne-Mette, et al.
Publicado: (2017)

Corrigendum: An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
por: Bjerregaard, Anne-Mette, et al.
Publicado: (2018)

Improved T cell receptor antigen pairing through data-driven filtering of sequencing information from single cells
por: Povlsen, Helle Rus, et al.
Publicado: (2023)

Neoantigen-reactive CD8(+) T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
por: Kristensen, Nikolaj Pagh, et al.
Publicado: (2022)

Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma
por: Holm, Jeppe Sejerø, et al.
Publicado: (2022)

The antigen specific composition of melanoma tumor infiltrating lymphocytes?
por: Hadrup, Sine Reker
Publicado: (2012)

T Cell Epitope Prediction and Its Application to Immunotherapy
por: Schaap-Johansen, Anna-Lisa, et al.
Publicado: (2021)

MHC-based detection of antigen-specific CD8(+) T cell responses
por: Hadrup, Sine Reker, et al.
Publicado: (2010)

Comment on “5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity”
por: Frøsig, Thomas Mørch, et al.
Publicado: (2015)

5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies
por: Gang, A O, et al.
Publicado: (2014)

“Immunotherapy of cancer: present status and future promise”: Danish Cancer Society Symposium, Copenhagen, Denmark, 23rd–25th September 2013
por: Donia, Marco, et al.
Publicado: (2014)

T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients
por: Viborg, Nadia, et al.
Publicado: (2019)

Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation
por: Ørskov, Andreas D., et al.
Publicado: (2015)

Inflammatory Cytokine Profiles Do Not Differ Between Patients With Idiopathic Cytopenias of Undetermined Significance and Myelodysplastic Syndromes
por: Nielsen, Amalie Bach, et al.
Publicado: (2022)

Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy
por: Borch, Annie, et al.
Publicado: (2023)

TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
por: Tvingsholm, Siri Amanda, et al.
Publicado: (2023)

Optimization in Detection of Antigen‐Specific T Cells Through Differentially Labeled MHC Multimers
por: Pedersen, Natasja Wulff, et al.
Publicado: (2019)

Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
por: Bjoern, Jon, et al.
Publicado: (2018)

Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
por: Bjoern, Jon, et al.
Publicado: (2017)

Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes
por: Hulen, Thomas Morgan, et al.
Publicado: (2023)

NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCRα and β sequence data
por: Montemurro, Alessandro, et al.
Publicado: (2021)

Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types
por: Araujo B. de Lima, Vinicius, et al.
Publicado: (2021)

Broadening the repertoire of melanoma-associated T-cell epitopes
por: Frøsig, Thomas Mørch, et al.
Publicado: (2015)

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients
por: Iversen, Trine Zeeberg, et al.
Publicado: (2013)

The splicing factor RBM17 drives leukemic stem cell maintenance by evading nonsense-mediated decay of pro-leukemic factors
por: Liu, Lina, et al.
Publicado: (2022)

High frequency of T cells specific for cryptic epitopes in melanoma patients
por: Andersen, Rikke Sick, et al.
Publicado: (2013)

Novel Molecular Targets for Hepatocellular Carcinoma
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021)

Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy
por: Tumas, Sarunas, et al.
Publicado: (2023)

Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
por: Hadrup, Sine, et al.
Publicado: (2012)

Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials
por: Ormhøj, Maria, et al.
Publicado: (2022)

Evaluation of Risk Scores as Predictive Tools for Stroke in Patients with Retinal Artery Occlusion: A Danish Nationwide Cohort Study
por: Ørskov, Marie, et al.
Publicado: (2022)

Cryopreservation of MHC Multimers: Recommendations for Quality Assurance in Detection of Antigen Specific T Cells
por: Hadrup, Sine Reker, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1ld4kg9fdu637pp0oviqset1hp